Clinical Trial Update: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers [Phase 1]

View source ↗

Summary

A multicenter Phase 1 postmarketing study evaluating the concentration of certolizumab pegol (Cimzia) in mature breast milk of lactating mothers; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis
• Crohn Disease
• Non-radiographic Axial Spondyloarthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA | Phase 1 | Status: COMPLETED | Results posted: 2017-02-06